Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHF 53.00
-1.67%
(-0.90) 1D
Apr 24, 5:30:01 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for BSLN...
Open
CHF 54.20
High
CHF 54.20
Low
CHF 52.80
Mkt. cap
706.08M
Avg. vol.
32.29K
Volume
16.46K
P/E ratio
18.02
52-wk high
CHF 59.70
52-wk low
CHF 41.20
EPS
CHF 2.94
Shares outstanding
13.32M
No. of employees
189
News stories
From sources across the web
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil
CEODavid Veitch
Employees189
Founded2000
Headquarters-
SectorBiotechnology
Websitebasilea.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
51.98M
51.98M
64.21M
64.21M
Cost of goods sold
31.26M
31.26M
41.35M
41.35M
Cost of revenue
31.26M
31.26M
41.35M
41.35M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.53M
8.53M
8.93M
8.93M
Operating expense
8.53M
8.53M
8.93M
8.93M
Total operating expenses
39.79M
39.79M
50.28M
50.28M
Operating income
12.19M
12.19M
13.93M
13.93M
Other non operating income
-1.83M
-1.83M
-309.00K
-309.00K
EBT including unusual items
9.67M
9.67M
13.26M
13.26M
EBT excluding unusual items
9.67M
9.67M
13.26M
13.26M
Income tax expense
1.77M
1.77M
1.05M
1.05M
Effective tax rate
18.31%
18.31%
7.89%
7.89%
Other operating expenses
-
-
-
-
Net income
7.90M
7.90M
12.22M
12.22M
Net profit margin
15.20%
15.20%
19.03%
19.03%
Earnings per share
-
-
-
-
Interest and investment income
277.50K
277.50K
357.50K
357.50K
Interest expense
-962.00K
-962.00K
-716.50K
-716.50K
Net interest expenses
-684.50K
-684.50K
-359.00K
-359.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
12.55M
12.55M
14.91M
14.91M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer